Abstract:Yuan-Qin Du, 1, &ast Bin Yuan, 1, &ast Yi-Xian Ye, 1 Feng-ling Zhou, 1 Hong Liu, 1 Jing-Jing Huang, 2 Yan-Fei Wei 3, 4 1 Graduate School, Guangxi University of Traditional Chinese Medicine, Nanning, 530200, People's Republic of China; 2 The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, 530024, People's Republic of China; 3 Department of Physiology, Guangxi University of Traditional Chinese Medicine, Nanning, 530200, People's Republic of China; 4 Guangxi Key Laboratory of Translational Medicine for Treating High-Incidence Infectious Diseases with Integrative Medicine, Nanning, 530200, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan-Fei Wei, Department of Physiology, Guangxi University of Traditional Chinese Medicine, No. 13 Wu He Road, Nanning, 530200, People's Republic of China, Tel/Fax +86-771-4733794, Email Background/Aims: Plumbagin (PL) has been shown to effe ctively inhibit autophagy, suppressing invasion and migration of hepatocellular carcinoma (HCC) cells. However, the specific mechanism remains unclear. This study aimed to investigate the effect of PL on tumor growth factor (TGF)-β-induced epithelial-mesenchymal transition (EMT) in HCC. Methods: Huh-7 cells were cultured, and in vivo models of EMT and HCC-associated lung metastasis were developed through tail vein and in situ injections of tumor cells. In vivo imaging and hematoxylin and eosin staining were used to evaluate HCC modeling and lung metastasis. After PL intervention, the expression levels of Snail, vimentin, E-cadherin, and N-cadherin in the liver were evaluated through immunohistochemistry and Western blot. An in vitro TGF-β-induced cell EMT model was used to detect Snail, vimentin, E-cadherin, and N-cadherin mRNA levels through a polymerase chain reaction. Their protein levels were detected by immunofluorescence staining and Western blot. Results: In vivo experiments demonstrated that PL significantly reduced the expression of Snail, vimentin, and N-cadherin, while increasing the expression of E-cadherin at the protein levels, effectively inhibiting HCC and lung metastasis. In vitro experiments confirmed that PL up-regulated epithelial cell markers, down-regulated mesenchymal cell markers, and inhibited EMT levels in HCC cells. Conclusion: PL inhibits Snail expression, up-regulates E-cadherin expression, and down-regulates N-cadherin and vimentin expression, preventing EMT in HCC cells and reducing lung metastasis. Keywords: plumbagin, hepatocellular carcinoma, epithelial-mesenchymal transition, pulmonary metastasis, Snail Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for approximately 75–85% of primary liver cancer cases. 1 It ranks as the sixth most prevalent malignant tumor globally 2 and has become the second leading cause of cancer-related deaths. 3 The low survival rate of HCC results from it being asymptomatic in the early stage. Timely diagnosis in the mid to late stages allows for extended survival through interventions like arterial chemoembolization and chemoradiotherapy. Delayed diagnosis often leads to metastasis, significantly impacting the efficacy of local or systemic treatment. 4 Lung metastasis accounts for 38.4–53.8% of extrahepatic metastases, being the most common type of extrahepatic metastasis of liver cancer. The one-year survival rate of patients with lung metastasis is approximately 10%. 5 Understanding the mechanisms underlying liver cancer recurrence and metastasis by focusing on epithelial-mesenchymal transformation (EMT), a phenomenon crucial for tumor development, invasion, and metastasis, is vital for improving overall treatment outcomes for patients with HCC. 6 EMT, a biological process, involves the morphological transformation of epithelial cells into mesenchymal cells, resulting in loss of cell polarity, cytoskeletal rearrangement, and increased mobility. 7 Key manifestations include the down-regulation of epithelial cell markers such as E-cadherin and β-catenin, and the up-regulation of mesenchymal cell markers such as N-cadherin and vimentin. 8 Tumor growth factor (TGF)-β/suppressor of mothers against decapentaplegic (Smad), Notch, and Wingless-related integration site (Wnt)/β-catenin are the main signaling pathways involved in EMT. Additionally, different signaling transduction pathways regulate the expression of EMT-related genes by activating small molecular weight transcription factors, known as EMT-induced transcription factors (EMT-TF), including Snai -Abstract Truncated-

Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Suppressing the Migration and Invasion of Tumor-Derived Vascular Endothelial Cells

Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2

Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA

Plumbagin Suppresses Endothelial Progenitor Cell-Related Angiogenesis in Vitro and in Vivo

Dddt_a_200610 1289..1300

Bioinformatic and Experimental Data Decipher the Pharmacological Targets and Mechanisms of Plumbagin Against Hepatocellular Carcinoma.

Plumbagin Promotes Human Hepatoma SMMC-7721 Cell Apoptosis Via Caspase-3/Vimentin Signal-Mediated EMT

Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells

Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions

Research on the anti-tumor effect of Plumbagin against human highly metastatic large cell lung cancer cell line

Plumbagin Shows Anti-Cancer Activity in Human Breast Cancer Cells by the Upregulation of P53 and P21 and Suppression of G1 Cell Cycle Regulators

Plumbagin Has an Inhibitory Effect on the Growth of TSCC PDX Model and It Enhances the Anticancer Efficacy of Cisplatin.

HGFK1 Enhances the Anti-Tumor Effects of Angiogenesis Inhibitors via Inhibition of CD90+ CSCs in Hepatocellular Carcinoma

Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro

Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition

Plasmid-encoding Vasostatin Inhibited the Growth and Metastasis of Human Hepatocellular Carcinoma Cells

Effects of Plumbagin on the Level of IL-2 and TNF-α in Tumor-Bearing Mice

HIF-1 α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo

Unveiling the anticancer potential of plumbagin: targeting pyruvate kinase M2 to induce oxidative stress and apoptosis in hepatoma cells

Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

Research on the antitumor mechanism of plumbagin to treat differentiated thyroid cancer based on network pharmacology and experimental validation